skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

HeartSmart® for routine optimization of blood flow and facilitation of early goal-directed therapy

Original Research

(1362) Views  (431) Full article downloads

Authors: Kenneth Warring-Davies, Martin Bland

Published Date August 2010 Volume 2010:2 Pages 115 - 123
DOI: http://dx.doi.org/10.2147/OAJCT.S9843

Kenneth Warring-Davies1, Martin Bland2
1The Intensive Care Unit, Bradford Royal Infirmary, Bradford, West Yorkshire, UK; 2Department of Health Sciences, University of York, York, North Yorkshire, UK

Abstract: The empirical physiological formulae of the new continuous cardiac dynamic ­monitoring HeartSmart® technology, which involves the use of a new inverse square rule of the heart, were investigated with pulmonary artery catheter (PAC) thermodilution in the ­estimation of CI in diverse patients. Clinical trial data collected from 268 adult surgery or intensive care patients requiring PAC placement were obtained from 7 NHS Trust hospitals, providing 2720 paired sets of CI estimations for comparison between HeartSmart® and PAC thermodilution. For 95% of pairs of measurements, HeartSmart® values were between 57% and 164% of PAC measurements; additionally, the larger limit of agreement between HeartSmart® and PAC thermodilution (1.26 L min-1•m-2) suggests that HeartSmart® agrees with PAC thermodilution as closely as PAC thermodilution agrees with itself. HeartSmart® can also estimate CI in the extreme circumstances of shock/sepsis, as indicated by PAC thermodilution CI values that were hypo- or hyperdynamic based on systemic inflammatory response syndrome criteria. In CI measurements for hypo- or hyperdynamic values that were matched between HeartSmart® and PAC thermodilution, the difference in total volumes and average CI measurements between the two methods was less than 5%. For unmatched hypo- or hyperdynamic values, the difference between total volumes and average CI measurements was less than 33% – an acceptable percentage of difference or error even for normal values of CI. HeartSmart® tracked PAC thermodilution CI hypodynamic values 98.2% of the time and hyperdynamic values 97.6% of the time. These findings show that CI estimations provided by the HeartSmart® empirical physiological formulae are comparable to those obtained using PAC thermodilution. HeartSmart® removes many of the technical barriers that prevent the routine adoption and practice of early goal-directed therapy, and represents a simple, reliable method of estimating CI and other hemodynamic variables at the bedside or in departments other than the Intensive Care Unit.

Keywords: cardiac index, early goal-directed therapy, HeartSmart®, cardiodynamics, blood flow






Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Pharmacological modeling and biostatistical analysis of a new drug
Time will tell: community acceptability of HIV vaccine research before and after the “Step Study” vaccine discontinuation
Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis
Erratum
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Critical illness outcome study: an observational study of protocols and mortality in intensive care units
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Is Patch It® better than placebo in alleviating swelling and ache in the lower legs and feet? A randomized, placebo-controlled, double blind, crossover, sequential trial
Variation in effect of intervention studies in research on sickness absence
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University